Pulmonx Corp. (LUNG)
2.28
+0.06
(+2.70%)
USD |
NASDAQ |
Dec 24, 16:00
Pulmonx Cash from Investing (Quarterly): 8.711M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IRIDEX Corp. | -0.013M |
| Stereotaxis, Inc. | 0.00 |
| Electromed, Inc. | -0.267M |
| Axogen, Inc. | -3.751M |
| Myomo, Inc. | 0.1897M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.185M |
| Cash from Financing (Quarterly) | 0.204M |
| Free Cash Flow | -32.64M |
| Free Cash Flow Per Share (Quarterly) | -0.2021 |
| Free Cash Flow to Equity (Quarterly) | -8.01M |
| Free Cash Flow to Firm (Quarterly) | -7.462M |
| Free Cash Flow Yield | -35.59% |